bullish
Hugel: Botulinum Injects Sales from Exports
270 Views10 Aug 2017 13:21
Strong sales momentum, low price volatility versus the Korean market,and improving asset turnover relative to its sector
In April, Hugel signed a...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 10-minute read)
Discussions
(Paid Plans Only)
Rising
A. Stotz Investment Research
Quantamental Investing to beat Benchmarks
Price Chart(Sign Up to Access)
- Korean Botox Players in Another Round of Patent Fights: Medytox (086900 KS) Sues Hugel (145020 KS)20 Apr 2022
- The Fight to Acquire Hugel - GS Group Led Consortium or Goldman Sachs Led Consortium?15 Aug 2021
- Hugel Placement: A 5.2% Block Deal Sale29 Jun 2020
- Hugel: Botulinum Injects Sales from Exports10 Aug 2017
x